TY - JOUR T1 - Neonatal white matter tract microstructure and 2-year language outcomes after preterm birth JF - medRxiv DO - 10.1101/19011361 SP - 19011361 AU - Sarah E. Dubner AU - Jessica Rose AU - Heidi M. Feldman AU - Katherine E. Travis Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/15/19011361.abstract N2 - Aim To determine whether variability in diffusion MRI (dMRI) white matter tract metrics, obtained in a cohort of preterm infants prior to neonatal hospital discharge, would be associated with language outcomes at age 2 years, after consideration of age at scan and number of major neonatal complications. Method: 30 children, gestational age 28.9 (2.4) weeks, underwent dMRI at mean post menstrual age 36.4 (1.4) weeks and language assessment with the Bayley Scales of Infant Developmentā€“III at mean age 22.2 (1.7) months chronological age. Mean fractional anisotropy (FA) and mean diffusivity (MD) were calculated for 5 white matter tracts. Hierarchical linear regression assessed associations between tract FA, moderating variables, and language outcomes. Results: FA of the left inferior longitudinal fasciculus accounted for 17% (p = 0.03) of the variance in composite language and FA of the posterior corpus callosum accounted for 19% (p = 0.02) of the variance in composite language, beyond that accounted for by post menstrual age at scan and neonatal medical complications. The number of neonatal medical complications moderated the relationship between language and posterior corpus callosum FA but did not moderate the association in the other tract. Conclusion: Language at 2 is associated with white matter metrics in early infancy in preterm children. The different pattern of associations by fiber group may relate to the stage of brain maturation and/or the nature and timing of medical complications related to preterm birth. Future studies should replicate these findings with a larger sample size to assure reliability of the findings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Institutes of Health [NICHD grant RO1-HD069162] and Health Resources and Services Administration Maternal Child Health Bureau [T77MC09796] to Heidi M. Feldman, PI, the National Institutes of Health [5K99HD084749] and the 2014 Society for Developmental and Behavioral Pediatrics Young Investigator Award to Katherine E. Travis, PI, and the Stanford Maternal Child Health Research Institute Tashia and John Morgridge Endowed Postdoctoral Fellowship to Sarah E. Dubner. This research was also supported by the Chiesi Foundation, Parma Italy; NIH Clinical and Translational Science Award UL1RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) and for Stanford Center for Clinical Informatics, Stanford Translational Research Integrated Database Environment (STRIDE); Lucile Packard Foundation for Children's Health; NSF Graduate Research Fellowship grant no. DGE-1147470, and by the Mary Baracchi Research Fund, Lucile Packard Children's Hospital at Stanford.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data will be made available upon request to qualified investigators for purposes of replicating procedures and results from the corresponding author. ER -